These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20551247)

  • 21. Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma.
    Noaman E; Badr El-Din NK; Bibars MA; Abou Mossallam AA; Ghoneum M
    Cancer Lett; 2008 Sep; 268(2):348-59. PubMed ID: 18554778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological and clinical aspects of alpha 1-antitrypsin with special reference to malignant tumor processes].
    Millán Núñez-Cortés J
    Rev Esp Oncol; 1981; 28(4):591-641 contd. PubMed ID: 6764960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitrogen movement between host and tumor in mice inoculated with Ehrlich ascitic tumor cells.
    Carrascosa JM; Martínez P; Núñez de Castro I
    Cancer Res; 1984 Sep; 44(9):3831-5. PubMed ID: 6146402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation and modulation of Ehrlich ascites tumor growth with tumor-plasma IgA.
    Ghosh AK; Saha S
    Indian J Exp Biol; 2000 Apr; 38(4):313-22. PubMed ID: 11218806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to tumor growth mediated by Listeria monocytogenes. Destruction of experimental malignant melanoma by LM-activated peritoneal and lymphoid cells.
    Youdim S
    J Immunol; 1976 Mar; 116(3):579-84. PubMed ID: 56396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral regulation of cell-mediated immunity to syngeneic tumor.
    Ting CC
    Cancer Res; 1976 Oct; 36(10):3695-701. PubMed ID: 953995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteases during the growth of Ehrlich ascites tumor. I. The fibrinolysin system.
    LeBlanc PP; Back N
    J Natl Cancer Inst; 1975 Apr; 54(4):881-6. PubMed ID: 123966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
    Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beta-glucuronidase in the ascitic fluid and serum of mice with Ehrlich ascites carcinoma].
    Nilius R; Peters JE
    Acta Biol Med Ger; 1967; 19(6):1011-6. PubMed ID: 5592031
    [No Abstract]   [Full Text] [Related]  

  • 30. [Express-method of determination of DNA-binding proteins in the mammalian blood].
    Novoradovskaia NA; Koterov AN; Filippovich IV
    Vopr Med Khim; 1990; 36(4):85-8. PubMed ID: 2238541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.
    Langlois AJ; Matthews T; Roloson GJ; Thiel HJ; Collins JJ; Bolognesi DP
    J Immunol; 1981 Jun; 126(6):2337-41. PubMed ID: 7229378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
    Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
    Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tumor effects of paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-alpha production.
    Sun GP; Wang H; Xu SP; Shen YX; Wu Q; Chen ZD; Wei W
    Eur J Pharmacol; 2008 Apr; 584(2-3):246-52. PubMed ID: 18329639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in the RNA content of the blood plasma in rats with Ehrlich ascitic cancer].
    Agliullina DG; Lapina LA; Vinter VG
    Eksp Onkol; 1988; 10(4):49-51, 62. PubMed ID: 2460309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemoglobin-associated proteins isolated from blood serum of Ehrlich carcinoma-bearing mice.
    Donenko FV; Sitdikova SM; Syrtsev AV; Gradyushko AT; Kiselevsky MV; Serebryakova MV; Efferth T
    Int J Oncol; 2008 Apr; 32(4):885-93. PubMed ID: 18360716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
    Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
    J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein electrophoretic patterns of serum and peritoneal fluid in normal, tumor-bearing, and immune mice.
    Brenneman M; Rigby P
    Cancer Res; 1968 Jun; 28(6):1138-42. PubMed ID: 4173141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.